XML 46 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Other Assets and Other Liabilities and Deferred Income
3 Months Ended
Mar. 31, 2019
Other Assets and Other Liabilities and Deferred Income [Abstract]  
OTHER ASSETS AND OTHER LIABILITIES AND DEFERRED INCOME
OTHER ASSETS AND OTHER LIABILITIES AND DEFERRED REVENUE

Other assets and other liabilities and deferred revenue consist of various balance sheet items that are combined for financial statement presentation due to their respective materiality compared with other individual asset and liability items.

Other assets were as follows (in millions):
 
December 31,
2018
 
March 31,
2019
Accrued interest and other non-finance receivables
$
1,080

 
$
1,116

Collateral held for resale, at net realizable value, and other inventory
877

 
737

Prepaid reinsurance premiums and other reinsurance recoverables
658

 
663

Deferred charges – income taxes
216

 
200

Property and equipment, net of accumulated depreciation (a)
192

 
200

Investment in non-consolidated affiliates
123

 
127

Restricted cash
140

 
121

Operating lease assets

 
92

Deferred charges
96

 
89

Other
74

 
97

Total other assets
$
3,456

 
$
3,442

__________
(a)
Accumulated depreciation was $367 million and $375 million at December 31, 2018 and March 31, 2019, respectively.

Other liabilities and deferred revenue were as follows (in millions):
 
December 31,
2018
 
March 31,
2019
Unearned insurance premiums and fees
$
775

 
$
779

Interest payable
752

 
637

Income tax and related interest (a)
369

 
329

Deferred revenue
113

 
126

Operating lease liabilities

 
94

Payroll and employee benefits
70

 
45

Other
228

 
208

Total other liabilities and deferred revenue
$
2,307

 
$
2,218


__________
(a)
Includes tax and interest payable to affiliated companies of $193 million and $182 million at December 31, 2018 and March 31, 2019, respectively.

We have investments in entities for which we do not have the ability to exercise significant influence and fair values are not readily available. We have elected to record these investments at cost (less impairment, if any), adjusted for changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We report the carrying value of these investments in Other assets in our consolidated balance sheet. These investments were $9 million at both December 31, 2018 and March 31, 2019. There were no material adjustments to the fair values of these investments during the period ending March 31, 2019.

Deferred revenue balances presented above include amounts from contracts with customers primarily related to admission fee revenue on group financing products available in Argentina and were $87 million and $76 million at December 31, 2018 and March 31, 2019, respectively. Admission fee revenue on group financing products is generally recognized evenly over the term of the agreement, which is up to 84 months. Increases in the admission fee deferred revenue balance are the result of payments due during the current period in advance of satisfying our performance under the contract and decreases are a result of revenue recognized during the current period that was previously deferred.